News March 2026

      Natalia is currently undergoing treatment with the targeted drug Trastuzumab, which, fortunately, is available within the budget. In addition, she is taking oral chemotherapy with the drug Capecitabine. An injection of the drug Ixgeva is administered once every three months. A routine CT scan is scheduled for April, which will allow the progression of the disease to be assessed.
      Natalia expresses her sincere gratitude to everyone who has contributed to the fundraising for her treatment. She wishes everyone good health and notes that without the support of caring people, her treatment would have been impossible.